petros grivas on the efficacy of sacituzumab govitecan for bladder cancer
Published 1 year ago • 79 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
3:37
uromiogs live 2023: dr. petros grivas on promising future treatments in bladder cancer
-
53:15
will new antibody drug conjugates cure bladder cancer?
-
8:03
panel discusses asco® gu data released on sacituzumab govitecan: real-world findings, unite trial
-
0:56
dr. grivas on the next steps for immunotherapy in bladder cancer
-
26:44
simon crabb and petros grivas on the most interesting trials presented at asco gu 2022.
-
6:39
rare and variant histologies in bladder cancer
-
31:26
the uromigos: bladder cancer buzzer round
-
5:03
atezolizumab with ebrt for bladder preservation in mibc
-
35:57
on target: using trop-2-directed therapeutics for urothelial carcinoma
-
1:31:33
maximizing the role of adcs in urothelial carcinoma
-
5:03
tumour immunology and immunotherapy
-
1:51
dr. grivas on checkpoint inhibitors in localized bladder cancer
-
1:56
dr. grivas on mechanisms of immune response in bladder cancer
-
1:45
petros grivas, md, phd, on combining immunotherapy and chemotherapy in metastatic bladder cancer
-
6:10
bladder cancer treatment review with dr. petros grivas and dr. sumanta pal
-
12:26
petros grivas, md | key takeaways on genitourinary cancer at 2019 asco direct highlights denver
-
1:12
petros grivas, md, phd, regarding the role of immunotherapy in metastatic bladder cancer
-
1:45
dr. grivas on unmet needs in advanced urothelial cancer
-
2:04
dr. grivas on the imvigor211 trial in metastatic urothelial carcinoma
-
1:55
dr. grivas on investigational immunotherapy approaches in localized bladder cancer
-
6:30
additional insights from javelin bladder 100 | petros grivas
-
3:52
petros grivas, md | advances in genitourinary cancer at 2019 asco direct highlights denver